NALBUPHINE HYDROCHLORIDE (NALBUPHINE HYDROCHLORIDE) — FDA Approval ANDA216050 (SOMERSET THERAPS LLC)
NALBUPHINE HYDROCHLORIDE (NALBUPHINE HYDROCHLORIDE) — FDA Approval ANDA216050 (SOMERSET THERAPS LLC) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: NALBUPHINE HYDROCHLORIDE; Active ingredients: NALBUPHINE HYDROCHLORIDE; Application number: ANDA216050.
| Brand name | NALBUPHINE HYDROCHLORIDE |
|---|---|
| Active ingredients | NALBUPHINE HYDROCHLORIDE |
| Application number | ANDA216050 |
| Sponsor | SOMERSET THERAPS LLC |
| Dosage form | SOLUTION |
| Route | INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS |
| Marketing status | Prescription |
| Products in application | 2 |
| First approval date | 20240919 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →